see table 1 . congress has also transferred funds from this account for purposes other than cbrn countermeasure procurement . the omnibus appropriations act , 2009 ( p.l . 111-8 ) transferred $412 million to hhs from the special reserve fund . of this amount , $137 million went to help respond to and prepare for pandemic influenza and $275 million went to fund countermeasure advanced development through the biomedical advanced research and development authority ( barda ; see " bioshield and barda " below ) . the consolidated appropriations act , 2010 ( p.l . 111-117 ) transferred $609 million to hhs . of this amount , $305 million went to barda for countermeasure advanced development and $304 million went to the national institute of allergy and infectious diseases ( niaid ) to fund basic research on biodefense and emerging infectious diseases . in fy2011 , the department of defense and full - year continuing appropriations act ( p.l . 112-10 ) transferred $415 million to barda for countermeasure advanced development . see table 1 . it has three main provisions . the first provision provides hhs expedited procedures for cbrn terrorism - related spending , including procuring products , hiring experts , and awarding research grants . the second provision creates a government - market guarantee by permitting the hhs secretary to obligate funds to purchase countermeasures while they still need several more years of development . the third provision authorizes the hhs secretary to temporarily allow the emergency use of countermeasures that lack food and drug administration ( fda ) approval . the project bioshield act did not appropriate any funds . instead , it authorized the appropriation of up to a total of $5.593 billion for procuring countermeasures from fy2004 through fy2013 . the department of homeland security appropriations act , 2004 ( p.l . 108-90 ) had previously appropriated this amount into a special reserve fund and provided explicit time windows during which the money could be obligated . 108-90 specified that $3.418 billion were available for obligation from fy2004 to fy2008 . the balance of the advance appropriation plus unobligated funds remaining from fy2004 to fy2008 became available in fy2009 for obligation from fy2009 to fy2013 . the project bioshield act specified that the funds in this dhs "biodefense countermeasures" account are only for the procurement of cbrn countermeasures using the project bioshield authorities and may not be used for other purposes , such as countermeasure development grants or program administration . the 111 th congress transferred the remaining balance in the dhs biodefense countermeasures account to the hhs public health and social services emergency fund account through the consolidated appropriations act , 2010 ( p.l . congress specified that these transferred funds are to remain available for obligation through fy2013 and to be used for only for project bioshield - related countermeasure purchases . the public health and social services emergency fund account also contains non - project bioshield - related money designated for other purposes . while congress advance - appropriated the 10-year program , it retains the power to increase or decrease the amount in the special reserve fund . congress removed $25 million from this account through rescissions enacted in the consolidated appropriations act , 2004 ( p.l .